Strain Name:
NOD.Cg-Ifngtm1Ts H2h4/HbmMmmh
Stock Number:
037140-MU
Citation ID:
RRID:MMRRC_037140-MU
Other Names:
IFNg-/- NOD.H-2h4
Major Collection:

Strain Information

Ifngtm1Ts
Name: interferon gamma; targeted mutation 1, Timothy Stewart
Synonyms: GKO, ifntm1Ts, IFNgamma-, gko, Ifntm/Ts, Ifn-gtm1Ts, IFN-gamma KO, IFN-gammaKO, Ifngtm1Ts, Ifngtm1Ts, IFNgamma KO, IFN-gammatm1Ts, ifgtm1, IFN-gamma KO, ifng-, IFN-gamma-, IFN-g KO
Type: Allele
Species: Mus musculus (mouse)
Chromosome: 10
Alteration at locus: Targeted Mutation
H2h4
Name: histocompatibility-2, MHC; h4 variant
Synonyms: H-2h4
Type: Allele
Species: Mus musculus (mouse)
Chromosome: 17
Alteration at locus: Targeted Mutation
H2
Name: histocompatibility-2, MHC
Synonyms: H-2, MHC-II
Type: Complex/Cluster/Region
Species: Mus musculus (mouse)
Chromosome: 17
Alteration at locus: Targeted Mutation
Ifng
Name: interferon gamma
Synonyms: IFN-gamma, Ifg
Type: Gene
Species: Mouse
Chromosome: 10
Alteration at locus: Targeted Mutation
NCBI: 15978
VEGA: 10
HGNC: HGNC:5438
Homologene: 55526
Genotype Determination
ES Cell Line
Not applicable
Phenotype
TEC H/P (no SAT). Anti-CD40 increases severity
Mammalian Phenotype Terms
Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: B6.129S7-Ifngtm1Ts )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: B6.129S7-Ifngtm1Ts/J )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: C.129S7(B6)-Ifngtm1Ts/J )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: C.129S7-Ifngtm1Ts )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: involves: 129S7/SvEvBrd )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: involves: 129S7/SvEvBrd * BALB/c )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: involves: 129S7/SvEvBrd * C57BL/6 )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: involves: 129S7/SvEvBrd * NOD )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: NOD.129S7(B6)-Ifngtm1Ts Prkdcscid )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: NOD.129S7(B6)-Ifngtm1Ts/DvsJ )

Allelic Composition: Ifngtm1Ts/Ifngtm1Ts (Genetic Background: NOD.129S7-Ifngtm1Ts )

Allelic Composition: H2h4/H2h4 (Genetic Background: NOD.Cg-H2h4 )

Allelic Composition: H2h4/H2g7 (Genetic Background: NOD.Cg-H2h4 )

MeSH Terms
  • Adoptive Transfer
  • Animals
  • Base Sequence
  • Chemokines/genetics
  • Hyperplasia
  • Interferon-gamma/deficiency
  • Interferon-gamma/genetics
  • Interferon-gamma/physiology
  • Lymphocytes/immunology
  • Lymphocytes/pathology
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, Knockout
  • RNA, Messenger/genetics
  • RNA, Messenger/metabolism
  • Receptors, Interferon/deficiency
  • Receptors, Interferon/genetics
  • Receptors, Interferon/physiology
  • Thyroid Gland/immunology
  • Thyroid Gland/pathology
  • Thyroiditis, Autoimmune/etiology
  • Thyroiditis, Autoimmune/immunology
  • Thyroiditis, Autoimmune/pathology
  • CD8-Positive T-Lymphocytes/immunology
  • CD8-Positive T-Lymphocytes/transplantation
  • Cell Proliferation
  • Cells, Cultured
  • Epithelial Cells/immunology
  • Epithelial Cells/pathology
  • Female
  • Fibrosis
  • Inflammation/immunology
  • Inflammation/pathology
  • Lymphocyte Activation/immunology
  • Mice, SCID
  • Organ Specificity/immunology
  • Severity of Illness Index
  • Spleen/immunology
  • Spleen/pathology
  • Spleen/transplantation
  • Apoptosis
  • Cell Proliferation/drug effects
  • Cyclin-Dependent Kinase Inhibitor p21/metabolism
  • Cyclin-Dependent Kinase Inhibitor p27/metabolism
  • Down-Regulation
  • Epithelial Cells/cytology
  • Epithelial Cells/metabolism
  • Proliferating Cell Nuclear Antigen/metabolism
  • Protein-Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt/antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt/physiology
  • Receptors, Transforming Growth Factor beta
  • Signal Transduction/physiology
  • Thyroid Gland/cytology
  • Thyroid Gland/metabolism
  • Transforming Growth Factor beta/physiology
  • Up-Regulation
  • Antibodies/physiology
  • Autoimmunity
  • CD40 Antigens/agonists
  • CD40 Antigens/biosynthesis
  • CD40 Antigens/immunology
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Inbred DBA
  • Primary Cell Culture
  • Autoantibodies/biosynthesis
  • B-Lymphocyte Subsets/immunology
  • B-Lymphocyte Subsets/metabolism
  • B-Lymphocyte Subsets/pathology
  • Chemokine CXCL13
  • Chemokines, CXC/biosynthesis
  • Cytokines/biosynthesis
  • Histocompatibility Antigens Class I/biosynthesis
  • Histocompatibility Antigens Class II/biosynthesis
  • Immunoglobulin G/biosynthesis
  • Interleukin-4/deficiency
  • Interleukin-4/genetics
  • Interleukin-4/physiology
  • Organ Specificity/genetics
  • Plasma Cells/pathology
  • Spleen/metabolism
  • T-Lymphocyte Subsets/pathology
  • Thyroiditis, Autoimmune/genetics
Strain Development
The NOD.Cg-Ifngtm1Ts H2h4/Hbm was generated by crossing NOD.129S7(B6)-Ifngtm1Ts/DvsJ males with NOD.Cg-H2h4/DilTacUmmJ females then crossing F1 offsprig to yield F2 mice. These were selected for absence of the NOD MHC and presence of the NOD.H2h4 MHC (K haplotype) and presence of the homozygous mutant.
MMRRC Genetic QC Summary
The MMRRC Centers have developed a genetic QC pipeline using MiniMUGA array genotyping to provide additional information on strain backgrounds for MMRRC congenic and inbred strains. For more information on when data may be available, or to request genotyping for a strain of interest, please contact mmrrc@missouri.edu. Older strains may not have this information.
  • Immunology and Inflammation
Donor
Helen Braley-Mullen, Ph.D., University of Missouri.
Primary Reference
  • Yu, S., Sharp, G. C. and Braley-Mullen, H. Thyrocyte epithelial cell hyperplasia in IFNgamma-deficient NOD.H-2h4 mice. Clin. Immunol. 118: 92-100, 2006. Create an account http://www.deepdyve.com/lp/elsevier/thyroid-epithelial-cell-hyperplasia-in-ifn-deficient-nod-h-2h4-mice-v8t4GzesC0
  • Yu S, Sharp GC, Braley-Mullen H. Thyrocytes responding to IFNgamma are essential for development of lymphocytic autoimmune thyroiditis and inhibition of thyrocyte hyperplasia. J Immunol. 2006 Jan 15;176(2):1259-65. (Medline PMID: 16394017).
  • Yu S, Fang Y, Sharav T, Sharp GC, Braley-Mullen H. CD8+ T cells induce thyroid epithelial cell hyperplasia and fibrosis. J Immunol. 2011 Feb 15;186(4):2655-62. Epub 2011 Jan 10. (Medline PMID: 21220693).
  • Fang Y, Yu S, Braley-Mullen H.TGF-beta promotes proliferation of thyroid epithelial cells in IFNgamma-/- mice by downregulation of p21 and p27 via AKT pathway. Am J Pathol. 2012 Feb;180(2):650-60. Epub 2011 Nov 24. (Medline PMID: 22119715).
  • Kayes T, Fang Y, Yu S, Downey E, Wang S, Braley-Mullen H. Anti-CD40 induces thyrocyte proliferation and promotes thyroid autoimmunity by increasing CD40 expression on thyroid epithelial cells. J Immunol. 2013 Apr 15;190(8):3928-38. Epub 2013 Mar 15. (Medline PMID: 23509363).
  • Yu, S., Downey, E. and Braley-Mullen, H. 2013. Agonistic anti-CD40 promotes early development and increases the incidence of severe thyroid epithelial cell hyperplasia (TEC H/P) in CD4-/- mice. Immun Inflamm Dis. 2013 Oct;1(1):14-25. (Medline PMID: 25400914)
  • Yu S, Sharp GC, Braley-Mullen H. Dual roles for IFNgamma, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol. 2002 Oct 1;169(7):3999-4007. (Medline PMID: 12244202).

Colony and Husbandry Information

Colony Surveillance Program and Current Health Reports

Mice recovered from a cryo-archive will have health surveillance performed on recipient females. Health reports will be provided prior to shipment. If you require additional health status information, please email mmrrc@missouri.edu.

Order Request Information

Limited quantities of breeder mice (recovered litter) are available from a cryoarchive; recovered litter usually available to ship in 3 to 4 months.

Cryopreserved material may be available upon request, please inquire to mmrrc@missouri.edu for more information.

Distribution of this strain requires submission of the MMRRC Conditions of Use (COU). A link to the COU web form will be provided via email after an order has been placed; the form should be completed then or the email forwarded to your institutional official for completion.

Additional charges may apply for any special requests. Shipping costs are in addition to the basic distribution/resuscitation fees. Information on shipping costs and any additional charges will be provided by the supplying MMRRC facility.

Click button to Request this one strain. (Use the MMRRC Catalog Search to request more than one strain.)
MMRRC Item # Description Distribution Fee / Unit (US $)
*Shipping & Handling not included*
Units Notes
037140-MU-EMBRYO Cryo-preserved embryos $1,038.00 / $2,621.00
Non-Profit / For-Profit
Aliquot Approximate quantity2 : 20-40 embryos / aliquot
037140-MU-RESUS Litter recovered from cryo-archive $2,028.00 / $4,127.00
Non-Profit / For-Profit
Litter Recovered litter4; additional fees for any special requests.
Cryopreserved material may be available upon request, please inquire to mmrrc@missouri.edu for more information.

1 The distribution fee covers the expense of rederiving mice from a live mouse; you will receive the resulting litter. The litter will contain at minimum one mutant carrier; the actual number of animals and the gender and genotype ratios will vary. (Typically, multiple breeder pairs can be established from the recovered litter.) Prior to shipment, the MMRRC will provide information about the animals recovered. If you anticipate or find that you need to request specific genotypes, genders or quantities of mice in excess of what is likely from a resuscitated litter, you may discuss available options and pricing with the supplying MMRRC facility.

2 An aliquot contains a sufficient number of embryos (in one or more vials or straws and based on the transfer success rate of the MMRRC facility) to transfer into one to three recipients. The MMRRC makes no guarantee concerning embryo transfer success experienced in the recipient investigator's laboratory. Neither gender nor genotype ratios are guaranteed.

3 An aliquot is one straw or vial with sufficient sperm to recover at least one litter of mice, as per provided protocols, when performed at the MMRRC facility. The MMRRC makes no guarantee concerning the success of these procedures when performed outside the MMRRC facilities.

4 The distribution fee covers the expense of resuscitating mice from the cryo-archive; you will receive the resulting litter. The litter will contain at minimum one mutant carrier; the actual number of animals and the gender and genotype ratios will vary. (Typically, multiple breeder pairs can be established from the recovered litter.) Prior to shipment, the MMRRC will provide information about the animals recovered. If you anticipate or find that you need to request specific genotypes, genders or quantities of mice in excess of what is likely from a resuscitated litter, you may discuss available options and pricing with the supplying MMRRC facility.

To request material from the MMRRC: Please fill out our on-line request form (accessible from the catalog search results page, or click the Request this Strain button in the fees section). If you have questions or need assistance completing this form, you may call Customer Service at (800) 910-2291 (in USA or Canada) or (530) 757-5710 (international calls). Before you call, please have with you: the MMRRC item number, quantity needed, Bill-to and Ship-to contact information.